47 related articles for article (PubMed ID: 29783310)
1. Application of pharmacogenomics to clinical problems in depression.
Oestergaard S; Møldrup C
Per Med; 2009 Sep; 6(5):501-515. PubMed ID: 29783310
[TBL] [Abstract][Full Text] [Related]
2. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
[TBL] [Abstract][Full Text] [Related]
3. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.
Serretti A; Benedetti F; Zanardi R; Smeraldi E
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1074-84. PubMed ID: 15939518
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis.
Mak KK; Kong WY; Mak A; Sharma VK; Ho RC
J Neurol Neurosurg Psychiatry; 2013 Mar; 84(3):322-8. PubMed ID: 23236014
[TBL] [Abstract][Full Text] [Related]
5. Novel procedure for genotyping of the human serotonin transporter gene-linked polymorphic region (5-HTTLPR)--a region with a high level of allele diversity.
Rasmussen HB; Werge TM
Psychiatr Genet; 2007 Oct; 17(5):287-91. PubMed ID: 17728667
[TBL] [Abstract][Full Text] [Related]
6. The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.
Breitenstein B; Scheuer S; Pfister H; Uhr M; Lucae S; Holsboer F; Ising M; Brückl TM
CNS Spectr; 2014 Apr; 19(2):165-75. PubMed ID: 23880209
[TBL] [Abstract][Full Text] [Related]
7. The association of serotonin transporter gene polymorphism and geriatric depression: a meta-analysis.
Gao Z; Yuan H; Sun M; Wang Z; He Y; Liu D
Neurosci Lett; 2014 Aug; 578():148-52. PubMed ID: 24996193
[TBL] [Abstract][Full Text] [Related]
8. Association of serotonin transporter promoter gene polymorphism (5-HTTLPR) with depression in Costa Rican schizophrenic patients.
Contreras J; Hernández S; Quezada P; Dassori A; Walss-Bass C; Escamilla M; Raventos H
J Neurogenet; 2010 Jul; 24(2):83-9. PubMed ID: 20397838
[TBL] [Abstract][Full Text] [Related]
9. Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression.
Kautto M; Kampman O; Mononen N; Lehtimäki T; Haraldsson S; Koivisto PA; Leinonen E
Neurosci Lett; 2015 Mar; 590():116-20. PubMed ID: 25650523
[TBL] [Abstract][Full Text] [Related]
10. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression.
Taylor WD; Steffens DC; Payne ME; MacFall JR; Marchuk DA; Svenson IK; Krishnan KR
Arch Gen Psychiatry; 2005 May; 62(5):537-44. PubMed ID: 15867107
[TBL] [Abstract][Full Text] [Related]
11. 5-HTTLPR modulates antidepressant efficacy in depressed women.
Gressier F; Bouaziz E; Verstuyft C; Hardy P; Becquemont L; Corruble E
Psychiatr Genet; 2009 Aug; 19(4):195-200. PubMed ID: 19451862
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in serotonergic pathways influence the outcome of antidepressant therapy in psychiatric inpatients.
Staeker J; Leucht S; Laika B; Steimer W
Genet Test Mol Biomarkers; 2014 Jan; 18(1):20-31. PubMed ID: 24192302
[TBL] [Abstract][Full Text] [Related]
13. Serotonin transporter gene and response to lithium augmentation in depression.
Stamm TJ; Adli M; Kirchheiner J; Smolka MN; Kaiser R; Tremblay PB; Bauer M
Psychiatr Genet; 2008 Apr; 18(2):92-7. PubMed ID: 18349701
[TBL] [Abstract][Full Text] [Related]
14. Contribution of allelic variations in transporters to the phenotype of drug response.
Kirchheiner J; Gründemann D; Schömig E
J Psychopharmacol; 2006 Jul; 20(4 Suppl):27-32. PubMed ID: 16785267
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of genotyping cytochrome P450 enzymes in the treatment of depression.
Dubovsky SL
Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):369-79. PubMed ID: 25554071
[TBL] [Abstract][Full Text] [Related]
16. Significance of serotonin transporter gene polymorphism in tinnitus.
Deniz M; Bayazit YA; Celenk F; Karabulut H; Yilmaz A; Gunduz B; Saridogan C; Dagli M; Erdal E; Menevse A
Otol Neurotol; 2010 Jan; 31(1):19-24. PubMed ID: 19924014
[TBL] [Abstract][Full Text] [Related]
17. Serotonin transporter polymorphisms (5-HTTLPR) in emotion processing: implications from current neurobiology.
Jonassen R; Landrø NI
Prog Neurobiol; 2014 Jun; 117():41-53. PubMed ID: 24548605
[TBL] [Abstract][Full Text] [Related]
18. Association between the 5-HT1A receptor gene polymorphism (rs6295) and antidepressants: a meta-analysis.
Zhao X; Huang Y; Li J; Ma H; Jin Q; Wang Y; Wu L; Zhu G
Int Clin Psychopharmacol; 2012 Nov; 27(6):314-20. PubMed ID: 22890315
[TBL] [Abstract][Full Text] [Related]
19. Initial conditions of psychotropic drug response: studies of serotonin transporter long promoter region (5-HTTLPR), serotonin transporter efficiency, cytokine and kinase gene expression relevant to depression and antidepressant outcome.
Rausch JL
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1046-61. PubMed ID: 16005136
[TBL] [Abstract][Full Text] [Related]
20. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
